| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |